LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS

Clinical trials for LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS explained in plain language.

Never miss a new study

Get alerted when new LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS trials appear

Sign up with your email to follow new studies for LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a liver artery injection boost cancer treatment?

Disease control Ongoing

This early-phase study tests if giving the drug Lutathera directly into the liver's main artery is safe and practical for people with neuroendocrine tumors that have spread mostly to the liver. Ten adults with this type of cancer will receive two injections into the liver artery,…

Matched conditions: LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 09, 2026 04:33 UTC

LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS

Get alerted when new LIVER-DOMINANT METASTATIC PANCREATIC NEUROENDOCRINE TUMORS trials appear

Could a liver artery injection boost cancer treatment?